The advent of blockchain technology has transformed traditional business processes from centralized to decentralized. By eliminating the unnecessary intervention of middlemen, it can reduce the overall cost of patient medication by turning the drug supply chain entirely into a point-to-point decentralized business. This paper presents a reliable and encouraging P2P drug trading block chain technology and four related smart contracts. These contracts include consumer contracts and the supply, bidding and trading of drugs, which have been deployed on the Ethereum blockchain for the decentralized trading of drugs. We will use the Approach of Real cost descending (RCD) to achieve incentive transactions for suppliers and patients. This method provides P2P transactions and ensures the safety and transparency of drug data, as well as the anonymity of users in the transaction process. Finally, according to the requirements of Good Supplying Practice(GSP), the effectiveness of the proposed model is evaluated and analyzed.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.